Status:
COMPLETED
Don't Throw Your Heart Away: Layperson Study 1
Lead Sponsor:
Carnegie Mellon University
Conditions:
Cardiac Transplant Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Publicly available outcome assessments for transplant programs do not make salient that some programs tend to reject many of the hearts they are offered, whereas other programs accept a broader range ...
Detailed Description
Publicly available outcome assessments for transplant programs do not make salient that some programs tend to reject many of the hearts they are offered, whereas other programs accept a broader range ...
Eligibility Criteria
Inclusion
- Participants who are already qualified mTurk workers with Worker Accounts meeting the above criteria will be asked to participate if they confirm the following inclusion criteria in the consent form.
- 18 years of age or older
- must read and understand the information in the consent form
- must want to participate in the research and continue with the survey
- must live in United States
Exclusion
- Participants on mTurk will not be allowed to participate if they fail to pass the initial "bot screening", a multiple-choice question that asks, "What phone number should you dial when there is an emergency?" The obvious correct response in this screening question is "911", so participants who select one of the incorrect responses (i.e. "1-800-ANTIBOT", "1-877-MTURKER", "123") are filtered out and not allowed to complete the survey.
- Participants on mTurk will be allowed to participate, but excluded from data analysis, if they submit a nonsense response to the free-response question which reads, "In your own words, why do you think patients should choose the hospital you picked?" This question takes place after the participant has viewed the choice stimuli and selected their response. If participants input nonsense in the text response box, they will be permitted to complete the survey and paid, but filtered out from the data analysis.
Key Trial Info
Start Date :
November 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2020
Estimated Enrollment :
1019 Patients enrolled
Trial Details
Trial ID
NCT04133831
Start Date
November 15 2019
End Date
April 30 2020
Last Update
October 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Carnegie Mellon University
Pittsburgh, Pennsylvania, United States, 15213